Analyst firms · Barclays · MEDP

Barclays MEDP price target and rating history

Medpace Holdings Inc. (MEDP) · Health Care

Barclays rates Medpace Holdings Inc. (MEDP) Equal Weight with a $500 price target, as of its latest action on Mar 6, 2026. It has published 3 rating actions on MEDP since June 2025, including 1 upgrade and 1 downgrade. Across 7 firms with a MEDP price target in the last 12 months, the median target is $522. Barclays's $500 is 4% below that.

Current rating
Equal Weight
Price target
$500
Median target, all firms
$522
Actions on MEDP
3

Barclays price target on MEDP

$500$400$3002026
Barclays price target on MEDP, each point a stated target, June 2025 to March 2026.

Every Barclays rating on MEDP

How other firms rate MEDP

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
UBSNeutral$673Sep 30, 2026
Robert W. BairdNeutral$547Jul 8, 2026
JefferiesHold$515Jul 7, 2026
BarclaysEqual Weight$500Mar 6, 2026
RBC Capital MarketsOutperform$522Mar 3, 2026
TD CowenHold$419Feb 18, 2026
BMO Capital MarketsMarket Perform$600Nov 13, 2025

Questions about Barclays and MEDP

What is Barclays's price target for MEDP?
Barclays's latest stated price target for Medpace Holdings Inc. (MEDP) is $500, from its action on Mar 6, 2026.
What is Barclays's rating on MEDP?
Barclays rates MEDP Equal Weight, a neutral rating, as of Mar 6, 2026.
When did Barclays last change its view on MEDP?
On Mar 6, 2026, Barclays upgrades to Equal Weight from Underweight, price target $500.
How does Barclays's MEDP target compare with other analysts?
Across 7 firms with a MEDP price target in the last 12 months, the median target is $522. Barclays's $500 is 4% below that.

More MEDP rating histories

All Barclays ratingsMEDP news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.